Inventor
XIE LINGHONG
US27 patents
⚠️ This page may combine multiple inventors who share the name “XIE LINGHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
12 patentsUS6653471B2Nov 25, 2003
Heterocyclic compounds as ligands of the GABAA receptor
NEUROGEN CORP54 citations94
US6982268B2Jan 3, 2006
Substituted imidazolylmethyl pyridine and pyrazine derivatives GABAA receptor ligands
NEUROGEN CORP7 citations73
US7795262B2Sep 14, 2010
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
NEUROGEN CORP3 citations63
US6936617B2Aug 30, 2005
Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligands
NEUROGEN CORP6 citations62
US6743817B2Jun 1, 2004
Substituted fused pyrroleimines and pyrazoleimines
NEUROGEN CORP2 citations62
US7728009B1Jun 1, 2010
Thiazole amides, imidazole amides and related analogues
NEUROGEN CORP6 citations61
US7851474B2Dec 14, 2010
Dipiperazinyl ketones and related analogues
NEUROGEN CORP3 citations60
US7271170B2Sep 18, 2007
Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
NEUROGEN CORP1 citations52
US7282498B2Oct 16, 2007
Substituted fused pyrroleoximes and fused pyrazoleoximes
NEUROGEN CORP0 citations51
US6951864B2Oct 4, 2005
4-imidazol-1-ylmethyl-pyrimidine derivatives
NEUROGEN CORP1 citations51
US7351826B2Apr 1, 2008
Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
NEUROGEN CORP0 citations41
US7122546B2Oct 17, 2006
Imidazol-1-ylmethyl pyridazine derivatives
NEUROGEN CORP0 citations41
SUNOVION PHARMACEUTICALS INC
10 patentsUS10196403B2Feb 5, 2019
Compounds and compositions and uses thereof
SUNOVION PHARMACEUTICALS INC8 citations82
US10336732B2Jul 2, 2019
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
SUNOVION PHARMACEUTICALS INC7 citations81
US9856238B2Jan 2, 2018
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
SUNOVION PHARMACEUTICALS INC2 citations70
US10562916B2Feb 18, 2020
Substituted quinoxalines as PDE-10 inhibitors
SUNOVION PHARMACEUTICALS INC4 citations69
US11491133B2Nov 8, 2022
Heteroaryl-isochroman compounds and uses thereof
SUNOVION PHARMACEUTICALS INC2 citations68
US10780074B2Sep 22, 2020
Compounds and uses thereof
SUNOVION PHARMACEUTICALS INC2 citations68
US11192885B2Dec 7, 2021
1-heterocyclyl isochromanyl compounds and analogs for treating CNS disorders
SUNOVION PHARMACEUTICALS INC0 citations60
US9834564B2Dec 5, 2017
Substituted quinolines as PDE-10 inhibitors
SUNOVION PHARMACEUTICALS INC0 citations52
US9951088B2Apr 24, 2018
D2 receptor modulators and methods of use thereof in the treatment of diseases and disorders
SUNOVION PHARMACEUTICALS INC0 citations33
US9580409B2Feb 28, 2017
Modulators of opioid receptors and methods of use thereof
SUNOVION PHARMACEUTICALS INC0 citations30